Looking at the charts of the Psychedelics sector, they can best be described as a mixed bag. Just like Cannabis, shroom stocks are taking a hit. This could just…
Mind Cure
Mind Cure Health (MCUR.C) announced the development of two proprietary ketamine-enhanced protocols specifically for pain management and another for depression, according to a press release. Depression is basically…
Mind Cure (MCUR.C), a leader in advanced proprietary technology for psychedelic therapy, has provided updates regarding its financial position, near-term revenue strategy, and a timeline for iSTRYM’s market launch….
Mind Cure Health (MCUR.C) has entered into a partnership and licensing deal with SOMA Breath Inc. “We think it is important to give individuals options in building their mental…
Mind Cure (MCUR.C) has partnered with Lucid Inc. to design custom psychedelic music experiences for the Company’s iSTRYM technology. “We are building first-of-its-kind functionality by pairing AI-driven music scapes…
Mind Cure (MCUR.C) has filed a provisional patent application with the U.S. Patent and Trademark Office for the Company’s iSTRYM proprietary digital therapeutics (DTx) tool. “When people think of…
Mind Cure Health (MCUR.C) released its latest formulation, an all-natural supplement called Mind Cure Teen today, according to a press release. Mind Cure Teen is intended to alleviate the…